Self-management of Post COVID-19 Syndrome Using Wearable Biometric Technology

Not Applicable

Completed

• Conditions: COVID-19
• Interventions: Other: Self-management of post COVID-19 respiratory outcomes

• Registration Number: NCT05507190
• Lead Sponsor: University of Manitoba

Brief Summary

The main objective of this pilot study is to evaluate the impact of a self-management intervention using wearable biometric technology on post-COVID-19 syndrome. In addition, this pilot-study will provide information regarding validity, feasibility, patient compliance and satisfaction, valuable for the design of a future large-scale study.

Detailed Description

This pilot-study uses a one-group before-after design. Subjects: a convenience sample of 20 adults 18 years and older in the Winnipeg Health Region with a post-COVID-19 infection (≥ 3 months since acute infection) complaining of mild to severe persistent respiratory symptoms. Intervention: using the participants' initial assessment, personal characteristics, main complaints/needs and goals, the therapist will adjust the exercise plan and personalize the recommendations (e.g. maximum heart rate) as well as instruct the patients about safety precautions (how to pace themselves, when to seek professional or emergency care). Participants will be encouraged to wear the smart shirt as much as they want during the 6 weeks (29), but at a minimum of 1-hour a day (M-F) including while performing the recommended exercises (30-45 min/3 times a week). They should self-monitor their biometric values trying to reach/stay within the target values while wearing the shirt using Hexoskin app installed on an iPad provided by the research team or on the participants' personal device if preferred. Patients will also complete an online survey reporting symptoms intensity and activities completed, 3 times a week (over 6 weeks). Participants would be able to contact the research assistant overseeing the intervention at any time of the study if they have questions or concerns (text message or email). Otherwise, they will receive a follow-up phone call every week or if a significant change in their biometrical data is identified.

Study Timeline

• Study First Submitted: 2022-07-28
• Study First Submitted QC: 2022-08-16
• Study First Posted: 2022-08-18
• Study Start: 2023-12-01
• Primary Completion: 2024-06-30
• Study Completion: 2024-06-30
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-02
• Last Update Posted: 2025-05-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Post-COVID-19 ≥ 3 months after infection.
• Mild to severe persistent respiratory symptoms
• Access to a home internet

Exclusion Criteria

• History of neurological disease or mental illness
• Inability to ambulate independently without supervision
• Inability to complete basic tasks on a smart phone or tablet

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
One arm	Self-management of post COVID-19 respiratory outcomes	Self-management group. This pilot-study uses a one-group before-after design.

Primary Outcome Measures

Name	Time	Method
Health-related quality of life	6 weeks	EuroQol five-dimensional questionnaire (0 "worse health" to 100 "best health")
Postural orthostatic hypotension	6 weeks	Orthostatic Stress Test (Postural transitions)
Change in lung capacity	6 weeks	It will be assessed using a SpiroBank Smart F/V multi parameter spirometer (MIR) at pre-post intervention and once a week in between to monitor changes. This portable spirometer, which is MDSAP approved and complaint with ATS/ERS guidelines, connects automatically via Bluetooth to an iOS \& Android compatible App (MIR Spirobank). It provides real time feedback through messages and animation on smartphone, to improve personal compliance during the test. The app can generate test results PDF printout with information regarding 19 parameters of lung capacity.
Change in dyspnea	6 weeks	Modified Borg Scale (0 "best" to 10 "worse dyspnea") will be used to assess dyspnea.
Change in fatigue	6 weeks	Fatigue severity scale (0 -7 "more fatigue") will be used to measure the severity of fatigue.
Chronic fatigue syndrome	6 weeks	DePaul Symptoms Questionnaire short form (DSQ-SF) (0 "not present" - 4 "very severe")
Exercise capacity	6 weeks	The 6-min walk test (6 MWT) and the one-minute sit-to-stand test

Secondary Outcome Measures

Name	Time	Method
Symptoms change	6 weeks	Participants will be ask to rate their symptoms from 0-10 using an online form (base on the baseline symptoms)
Patient satisfaction with the study	6 week	Participants will complete a short summary with questions regarding their satisfaction with the study

Trial Locations

Locations (1)

Riverview Health Centre; 🇨🇦 Winnipeg, Manitoba, Canada